Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AAX, Accutar, Anaptysbio, Biomarin, Candel, Centessa, DMK, Emergent, Ensysce, Evommune, Fusion, Karuna, Oblique, Oncozenge, Sutro, US Worldmeds, Vaxcyte, Vivus.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bioreference, Bioline, Femasys, Milestone Scientific, Nanovibronix, Novocure, Opsens, Prognos, Quest Diagnostics, Scipher Medicine, Rewalk Robitics.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Connect Biopharma, GSK, Myricx Bio, Wuxi Biologics, Simcere Pharmaceutical, SK Bioscience, Sosei Group.

Additional early-stage research and drug discovery news in brief, from: Abionyx Pharma, Cantargia, Cellcentric, Pharmabcine.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adhera, Aeglea, Akiram, Biodexa, GSK, Melior, RVL, Seelos, Scisparc, Sosei, Theseus, Xbrane.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accelerate Diagnostics, Bracco, Bruker, Blackford, Broncus, CMI, Inspiremd, Iridex, Jiangliang, Life Molecular, Lyniate, Median Technologies, Orbusneich, RTI Surgical, Siemens Healthineers, Strattasys, Ulrich.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Algernon, Bristol Myers, Evelo, Gradalis, J&J, March, Medicine, Merck, Scisparc, Seyltx, SK Bioscience.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Connect, Enanta, Genentech, IGC, Myricx, Oncozenge, Revive, Roche, Simcere, Skip, Wuxi.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Astellas, Chiesi Farmaceutici, Haisco Pharamceutical, Mayne Pharma, Propella, Qsam, Telix, Therapeuticsmd.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 2518542, Abliva, Acer, Astex, Astrazeneca, Avonlea-Drewry, Basilea, Bayer, Biosyent, Chiesi, Chr. Hansen, Gryphon, Haisco, Khiron, Mira, Miralogx, Neuren, Novozymes, Pfizer, Rion, Owl, Tracon and Zevra.